Yaz Pulmonary Embolism Lawsuit Filed by Florida Woman
Tiffany Littles, a 33-year-old woman in Jacksonville, Florida, claims she nearly died from taking Yaz birth control in July 2008. In recent Yaz and Yasmin lawsuit information, her Yaz lawyer announced that Littles has filed a Yaz pulmonary embolism lawsuit in the Philadelphia Court of Common Pleas in the hopes, as Littles stated, “this traumatic event does not happen to anyone else.”
Littles claims to have suffered a Yaz pulmonary embolism, cor pulmonale and deep vein thrombosis because of the drug. The first Yaz pulmonary embolism federal bellwether case is scheduled to begin in January 2012.
What is Yaz pulmonary embolism?
A Yaz pulmonary embolism is a sudden blockage inside an artery that goes to the lung, often as a result of a blood clot that traveled up from the leg. It’s a serious condition that can cause permanent harm to the lung, low levels of blood oxygen, damage to other body organs, even death.
What is Yaz deep vein thrombosis or DVT?
Yaz Deep vein thrombosis (DVT) occurs when a blood clot forms in a vein deep in the body, usually in the lower leg or thigh. Often related to Yaz pulmonary embolism, DVT can create the blood clot that then travels up through the body to block the artery to the lung.
What is Yaz cor pulmonale?
Yaz Cor pulmonale occurs when the right side of the heart fails, usually because of long-term high blood pressure in the pulmonary arteries—called pulmonary hypertension. This condition can be caused by chronic blood clots in the lungs, and may also be related to cases of Yaz pulmonary embolism.
Yaz lawyer claims Bayer failed to warn of serious side effects
Littles claims to have experienced all three of these conditions as a result of taking Yaz. She is one of thousands who have experienced Yaz pulmonary embolism, and claims the manufacturer Bayer did not do enough to warn the public and healthcare professionals of the risks involved in taking the birth control pill.
Study shows higher risk of Yaz side effects leading to blood clots
A study published in the British Medical Journal found that birth control pills containing drospirenone (Yaz, Yasmin, and generics) have a 6.3 higher risk of DVT or Yaz pulmonary embolism than other birth control pills. In April 2010, the FDA released a safety warning concerning Yasmin blood clots, and in June 2011 announced they were reviewing the safety of birth control pills like Yaz and Yasmin because of concerns they may raise a woman’s risk of blood clots more than other birth control pills.
Yaz and Yasmin lawsuit information: bellwether trials
Yaz and Yasmin lawyers are currently working on nearly 6,000 cases in Yaz federal multidistrict litigation (MDL), taking place in the Southern District of Illinois. (MDL consolidation means the discovery process proceeds in one court under one judge, but cases are decided on an individual basis.) The first bellwether trial is focused on Yaz pulmonary embolism. Mass tort consolidated litigation in New Jersey also has plans to proceed with its first Yaz pulmonary embolism trial in September 2012. Cases alleging Yaz pulmonary embolism will also proceed in California and Pennsylvania, with the first case in Pennsylvania scheduled for January 2012. So far, it’s unclear if Ms. Littles’ case will join the MDL or continue in Pennsylvania state court.
